Q2 2025 Holdings
Filed 2025-08-13 | 24 holdings | $246.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $22.0M | 206,952 | 8.9% |
| Disc Medicine Inc(IRON) | COM | 254604101 | $21.0M | 396,115 | 8.5% |
| Amylyx Pharmaceuticals Inc(AMLX) | COM | 03237H101 | $20.9M | 3,260,570 | 8.5% |
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $17.7M | 544,221 | 7.2% |
| Cogent Biosciences Inc(COGT) | COM | 19240Q201 | $16.5M | 2,297,524 | 6.7% |
| Celcuity Inc(CELC) | COM | 15102K100 | $15.8M | 1,185,520 | 6.4% |
| CG Oncology Inc(CGON) | COM | 156944100 | $15.3M | 586,647 | 6.2% |
| Xenon Pharmaceuticals Inc(XENE) | COM | 98420N105 | $14.7M | 468,364 | 5.9% |
| Dyne Therapeutics Inc(DYN) | COM | 26818M108 | $13.9M | 1,455,429 | 5.6% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $13.7M | 290,784 | 5.6% |
| Merus N V | COM | N5749R100 | $11.8M | 224,260 | 4.8% |
| Centessa Pharmaceuticals PLC(CNTA) | SPONSORED ADS | 152309100 | $10.4M | 793,327 | 4.2% |
| Lenz Therapeutics Inc(LENZ) | COM | 52635N103 | $10.0M | 342,312 | 4.1% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $7.3M | 58,181 | 3.0% |
| Ocular Therapeutix Inc(OCUL) | COM | 67576A100 | $6.8M | 728,576 | 2.7% |
| Ascendis Pharma A/S(ASND) | SPONSORED ADR | 04351P101 | $6.6M | 38,191 | 2.7% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $5.7M | 10,285 | 2.3% |
| Abivax SA(ABVX) | SPONSORED ADS | 00370M103 | $4.8M | 622,479 | 1.9% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $4.7M | 500,551 | 1.9% |
| Newamsterdam Pharma Company(NAMS) | ORDINARY SHARES | N62509109 | $4.0M | 220,695 | 1.6% |
| Contineum Therapeutics Inc(CTNM) | CL A | 21217B100 | $1.3M | 319,348 | 0.5% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $1.2M | 128,917 | 0.5% |
| Kalvista Pharmaceuticals Inc(KALV) | COM | 483497103 | $709.9K | 62,793 | 0.3% |
| Silence Therapeutics PLC(SLN) | ADS | 82686Q101 | $201.5K | 34,737 | 0.1% |